chr19-51003178-C-T

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_012315.2(KLK9):​c.686G>A​(p.Arg229Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,593,342 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )

Consequence

KLK9
NM_012315.2 missense

Scores

15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.0710
Variant links:
Genes affected
KLK9 (HGNC:6370): (kallikrein related peptidase 9) The protein encoded by this gene is a kallikrein-related serine protease. This gene is activated by steroid hormones in a human breast cancer cell line, making it a good marker for cancer detection. The encoded protein is found primarily in the cytoplasm.[provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.07469067).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KLK9NM_012315.2 linkc.686G>A p.Arg229Gln missense_variant Exon 5 of 5 ENST00000594211.2 NP_036447.1 Q9UKQ9-1Q2XQG6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KLK9ENST00000594211.2 linkc.686G>A p.Arg229Gln missense_variant Exon 5 of 5 1 NM_012315.2 ENSP00000469417.1 Q9UKQ9-1
ENSG00000269741ENST00000250366.6 linkn.686G>A non_coding_transcript_exon_variant Exon 5 of 7 2 ENSP00000250366.5

Frequencies

GnomAD3 genomes
AF:
0.0000137
AC:
2
AN:
146440
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000253
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000221
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000804
AC:
2
AN:
248846
AF XY:
0.00000744
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000152
AC:
22
AN:
1446902
Hom.:
0
Cov.:
31
AF XY:
0.0000153
AC XY:
11
AN XY:
719516
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33050
American (AMR)
AF:
0.00
AC:
0
AN:
43254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25816
East Asian (EAS)
AF:
0.000386
AC:
15
AN:
38886
South Asian (SAS)
AF:
0.0000596
AC:
5
AN:
83882
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52890
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5350
European-Non Finnish (NFE)
AF:
9.06e-7
AC:
1
AN:
1104112
Other (OTH)
AF:
0.0000168
AC:
1
AN:
59662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000137
AC:
2
AN:
146440
Hom.:
0
Cov.:
32
AF XY:
0.0000279
AC XY:
2
AN XY:
71750
show subpopulations
African (AFR)
AF:
0.0000253
AC:
1
AN:
39574
American (AMR)
AF:
0.00
AC:
0
AN:
14894
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3350
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4832
South Asian (SAS)
AF:
0.000221
AC:
1
AN:
4532
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10446
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
304
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
65632
Other (OTH)
AF:
0.00
AC:
0
AN:
1988
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Jan 12, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.686G>A (p.R229Q) alteration is located in exon 5 (coding exon 5) of the KLK9 gene. This alteration results from a G to A substitution at nucleotide position 686, causing the arginine (R) at amino acid position 229 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.21
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
12
DANN
Benign
0.95
DEOGEN2
Benign
0.19
T
Eigen
Benign
-0.86
Eigen_PC
Benign
-0.86
FATHMM_MKL
Benign
0.029
N
M_CAP
Benign
0.049
D
MetaRNN
Benign
0.075
T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
0.75
N
PhyloP100
-0.071
PrimateAI
Benign
0.22
T
Sift4G
Benign
0.36
T
Polyphen
0.18
B
Vest4
0.19
MutPred
0.39
Loss of glycosylation at P228 (P = 0.0474);
MVP
0.75
ClinPred
0.050
T
GERP RS
-0.54
PromoterAI
0.012
Neutral
Varity_R
0.055
gMVP
0.61
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1568557980; hg19: chr19-51506434; COSMIC: COSV51591384; COSMIC: COSV51591384; API